Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2 - PubMed (original) (raw)
Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2
Ya-peng Wang et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Apr.
Abstract
Objective: To evaluate the effects of melatonin (Mel) combined with cis-platinum (DDP) or methotrexate (MTX) on the proliferation of osteosarcoma cell line SaOS-2, and to explore whether Mel combined with DDP or MTX could play a synergistic antitumor effect.
Methods: SaOS-2 was treated with Mel alone or Mel combined with DDP or MTX. Cell counting kit-8 assay was used to measure the cell activities. Combination index(CI) value was used to evaluate the combined effects: CI<1 indicating synergetic effect, CI=1 additive, and CI>1 antagonistic.Flow cytometry was used to analyze cell cycle distribution and cell apoptosis.
Results: After treated with Mel (0.5,1,2,4,5 mmol/L), DDP (6.67, 16.67, 33.33, 66.66 μmol/L) or MTX(0.1, 0.5, 1, 2, 4 mmol/L)alone,SaOS-2 cell activities decreased in a dose-dependent manner (all P<0.05). The activities of SaOS-2 cell treated with both Mel (1 mmol/L) and DDP or MTX were significantly lower than that of DDP or MTX alone (all P<0.05).CI values of cells exposed to 1 mmol/L Mel plus 6.67, 16.67, 33.33, and 66.66 μmol/L DDP were 1.18, 1.21, 1.09, and 0.84, respectively,and CI values of cells exposed to 1 mmol/L Mel plus 0.1, 0.5, 1, 2, and 4 mmol/L MTX were 0.88, 0.88 ,0.83, 0.78, and 0.81, respectively. The G1-stage cells were increased and the S-stage cells were reduced when the cells were treated with Mel (1 mmol/L) alone or combined with MTX (0.5 mmol/L) (P<0.05). The S-stage cells were increased when the cells treated with MTX (0.5 mmol/L) (P<0.05). The apoptotic cells were increased when they treated with Mel (1 mmol/L) alone or combined with DDP (16.67 μmol/L) or MTX (0.5 mmol/L) (P<0.05). When the cells were treated with Mel combined with DDP or MTX, the apoptotic cells were more than that of DDP or Mel alone(P<0.05).
Conclusions: Mel can inhibit SaOS-2 cells activity,block the cell cycle at G1-stage,and induce apoptosis. Mel has an antagonistic effect with lower concentration of DDP but a synergistic effect with MTX or higher concentration of DDP.
Similar articles
- [Effect of C23 down-regulation on proliferation inhibition and apoptosis induced by cisplatin in human osteosarcoma SaOS-2 cells].
Wu B, Wang W, Li Z. Wu B, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;37(1):32-7. doi: 10.3969/j.issn.1672-7347.2012.01.006. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22349377 Chinese. - Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells.
Wang JJ, Li GJ. Wang JJ, et al. Genet Mol Res. 2014 Jul 24;13(3):5313-21. doi: 10.4238/2014.July.24.10. Genet Mol Res. 2014. PMID: 25078587 - MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate.
Jiang L, He A, He X, Tao C. Jiang L, et al. Oncol Lett. 2015 Dec;10(6):3769-3778. doi: 10.3892/ol.2015.3790. Epub 2015 Oct 9. Oncol Lett. 2015. PMID: 26788206 Free PMC article. - [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y, Chen X, Luo Z. Liu Y, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):592-6. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 24909280 Chinese. - Progress in the chemotherapeutic treatment of osteosarcoma.
Zhang Y, Yang J, Zhao N, Wang C, Kamar S, Zhou Y, He Z, Yang J, Sun B, Shi X, Han L, Yang Z. Zhang Y, et al. Oncol Lett. 2018 Nov;16(5):6228-6237. doi: 10.3892/ol.2018.9434. Epub 2018 Sep 12. Oncol Lett. 2018. PMID: 30405759 Free PMC article. Review.
Cited by
- Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway.
Wang L, Su Y, Choi WS. Wang L, et al. Int J Mol Sci. 2021 Sep 14;22(18):9907. doi: 10.3390/ijms22189907. Int J Mol Sci. 2021. PMID: 34576070 Free PMC article. - Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.
Lu KH, Lin RC, Yang JS, Yang WE, Reiter RJ, Yang SF. Lu KH, et al. Cells. 2019 Dec 12;8(12):1618. doi: 10.3390/cells8121618. Cells. 2019. PMID: 31842295 Free PMC article. Review. - Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis.
MacDonald IJ, Tsai HC, Chang AC, Huang CC, Yang SF, Tang CH. MacDonald IJ, et al. Int J Mol Sci. 2021 Aug 30;22(17):9435. doi: 10.3390/ijms22179435. Int J Mol Sci. 2021. PMID: 34502344 Free PMC article. Review. - Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data.
Xu N, Wang X, Wang L, Song Y, Zheng X, Hu H. Xu N, et al. Front Genet. 2022 Oct 11;13:1013737. doi: 10.3389/fgene.2022.1013737. eCollection 2022. Front Genet. 2022. PMID: 36303551 Free PMC article. - Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Lo Sardo F, Muti P, Blandino G, Strano S. Lo Sardo F, et al. Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913. Int J Mol Sci. 2017. PMID: 28878191 Free PMC article.